Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
30000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数30,000Shares
30,000 new shares; no treasury shares transferred
発行済株式総数
0.23% (exercise ratio subject to exercise restrictions; the monthly number of shares delivered represented approximately 0.08% of the number of issued shares as of the end of the month preceding the subject month)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. The exercise prices during the subject month were ¥91.80, ¥90.00, ¥90.90, ¥94.50 and ¥83.70. The minimum adjustment price is Not disclosed.
Number of Stock Acquisition Rights
Total issued: 76,370 rights; exercised during the subject month: 300 rights; unexercised rights remaining as of 30 April: 12,261 rights (1,226,100 shares)
Basis for determining the amount to be paid
The exercise price was ¥91.80 on 1 May, ¥90.00 on 7 May, ¥90.00 on 8 May, ¥94.50 from 11 to 15 May, ¥83.70 from 18 to 22 May, and ¥83.70 from 25 to 29 May. The calculation standard and discount or premium rate are Not disclosed.
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations.
Most recent equity financing
Issued on 30 December 2024: Fifth Series Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 30,000 new shares; no treasury shares transferred |
| Dilution Rate | 0.23% (exercise ratio subject to exercise restrictions; the monthly number of shares delivered represented approximately 0.08% of the number of issued shares as of the end of the month preceding the subject month) |
| Total number of issued shares | 37,250,900 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Basis for determining the amount to be paid | The exercise price was ¥91.80 on 1 May, ¥90.00 on 7 May, ¥90.00 on 8 May, ¥94.50 from 11 to 15 May, ¥83.70 from 18 to 22 May, and ¥83.70 from 25 to 29 May. The calculation standard and discount or premium rate are Not disclosed. |
| Exercise price | Subject to an exercise price adjustment clause. The exercise prices during the subject month were ¥91.80, ¥90.00, ¥90.90, ¥94.50 and ¥83.70. The minimum adjustment price is Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 76,370 rights; exercised during the subject month: 300 rights; unexercised rights remaining as of 30 April: 12,261 rights (1,226,100 shares) |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. |
| Most recent equity financing | Issued on 30 December 2024: Fifth Series Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.